Pierce Sells 16286 Shares of Boston Scientific Co. (NYSE:BSX) Stock

Angelo Anderson
March 13, 2018

For the current quarter, 24 analysts are projecting a mean EPS of $0.32/share. BMO Capital Markets reiterated a "buy" rating and set a $31.00 price target on shares of Boston Scientific in a research report on Wednesday, November 29th. The stock traded with the average Volume of 8.46 Million at the end of last session. Also, SVP David A. Pierce sold 5,152 shares of the company's stock in a transaction that occurred on Tuesday, January 9th. Shares of Boston Scientific Corporation (BSX) are trading -4.64% downward from the 52-week high mark and 18.82% above from the fifty two-week low mark. It has outperformed by 2.42% the S&P500.

Gamble Jones Investment Counsel decreased Microsoft Corp (MSFT) stake by 1.42% reported in 2017Q3 SEC filing. The stock of Caesars Entertainment Corporation (NASDAQ:CZR) earned "Underweight" rating by Barclays Capital on Monday, December 14. American Century Companies Inc. now owns 10,496,489 shares of the medical equipment provider's stock valued at $306,183,000 after buying an additional 2,352,297 shares in the last quarter. Boston Scientific Corp Com now has $39.34B valuation. The stock increased 2.23% or $2.11 during the last trading session, reaching $96.54. About 9,965 shares traded. Snap-on Incorporated (NYSE:SNA) has risen 2.47% since March 12, 2017 and is uptrending. It has outperformed by 17.55% the S&P500.

Analysts await Union Pacific Corporation (NYSE:UNP) to report earnings on April, 26. Td Asset invested in 84,333 shares or 0.03% of the stock. UNP's profit will be $1.31 billion for 20.64 P/E if the $1.66 EPS becomes a reality. Asset Mngmt One Company Ltd reported 2.19M shares or 0.15% of all its holdings. The shares were sold at an average price of $25.25, for a total value of $399,833.75.

Among 29 analysts covering Union Pacific Corporation (NYSE:UNP), 13 have Buy rating, 2 Sell and 14 Hold. Therefore 50% are positive. Newell Rubbermaid Inc. had 62 analyst reports since August 4, 2015 according to SRatingsIntel. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance. The rating was maintained by Jefferies on Friday, July 29 with "Hold". The firm has "Buy" rating given on Thursday, October 6 by Citigroup. TheStreet cut Boston Scientific from a "b" rating to a "c" rating in a research report on Monday, March 5th. Robert W. Baird maintained the stock with "Hold" rating in Thursday, September 14 report. The firm has "Equal-Weight" rating given on Monday, February 12 by Morgan Stanley. The rating was upgraded by Piper Jaffray on Wednesday, March 29 to "Overweight". (NYSE:KEG) has "Neutral" rating given on Friday, August 11 by Nomura. The rating was maintained by Jefferies on Friday, February 2 with "Hold".

Investors sentiment increased to 2.15 in 2017 Q3. Its up 0.07, from 1.16 in 2017Q2. The shares were sold at an average price of $27.00, for a total value of $139,104.00. 95 funds opened positions while 408 raised stakes. Eulav Asset Management reported 80,000 shares stake. 55 are owned by Contravisory Invest Management. Jpmorgan Chase Co has invested 0.33% in Boston Scientific Corporation (NYSE:BSX). Cambridge Investment Research Advsr Inc has 12,377 shares. California State Teachers Retirement System accumulated 20,594 shares. Colorado-based Denver Investment Limited Liability has invested 0.06% in Union Pacific Corporation (NYSE:UNP). Acadian Asset Ltd Llc holds 57,059 shares. 82,537 were reported by Brown Advisory. Fiera Cap Corporation holds 987,128 shares or 0.35% of its portfolio. Pensionfund Dsm Netherlands holds 16,000 shares or 0.36% of its portfolio. Moors Cabot invested in 0.21% or 49,975 shares.

Investors sentiment increased to 1.34 in Q3 2017. Its down 0.06, from 0.83 in 2017Q2. It increased, as 33 investors sold BSX shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. It also upped Vanguard Scottsdale Fds (VCSH) stake by 27,318 shares and now owns 98,958 shares. The fund owned 97,749 shares of the medical equipment provider's stock after acquiring an additional 8,688 shares during the quarter. Texas Permanent School Fund, a Texas-based fund reported 380,258 shares. Dupont Mngmt Corporation reported 0.01% stake. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. Commonwealth Equity Svcs owns 99,168 shares. Mufg Americas reported 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX). 235,258 are held by Cornerstone Cap Management Holdings Lc. Van Cleef Asset Managementinc accumulated 9,400 shares. Prudential Incorporated has invested 0.23% in Boston Scientific Corporation (NYSE:BSX). Moreover, Manning Napier Advisors Ltd Limited Liability Company has 1.87% invested in FedEx Corporation (NYSE:FDX).

Sector Gamma As, which manages about $656.08M US Long portfolio, decreased its stake in Abbott Labs (NYSE:ABT) by 265,600 shares to 1.27 million shares, valued at $67.86 million in 2017Q3, according to the filing.

Boston Scientific Corporation (NYSE:BSX) now has a "Buy" signals on Composite indicators by TrendSpotter. Therefore 68% are positive. The rating was upgraded by BTIG Research on Thursday, November 30 to "Buy". The firm earned "Buy" rating on Friday, September 1 by RBC Capital Markets. The firm has "Buy" rating given on Thursday, June 22 by Needham. As per Thursday, March 17, the company rating was maintained by UBS. Canaccord Genuity has "Buy" rating and $35.0 target. Moreover, First Republic Invest Mgmt has 0.02% invested in Boston Scientific Corporation (NYSE:BSX) for 99,055 shares. Wells Fargo downgraded the stock to "Market Perform" rating in Monday, May 1 report.

Other reports by Iphone Fresh

Discuss This Article